TORONTO, September 27, 2018 /CNW/ – PRESS RELEASE – FSD Pharma Inc. has announced that Horizons ETFs Management (Canada) Inc. has added the company to the Horizons Marijuana Life Sciences Index ETF (HMMJ:TSX) as part of the quarterly rebalance of the constituent holdings of HMMJ. The company stock has a 1.9 percent weighting in HMMJ. According to Horizons ETFs, “As of Sept. 5, 2018, HMMJ had reached over CAD $1 billion in assets under management–a rare achievement for the Canadian ETF marketplace.”
“We are thrilled to be included in HMMJ, which is the largest ETF offering direct exposure for investors to North American life sciences companies that have significant business activities in the marijuana industry. FSD Pharma expects to continue to deliver on its current business strategy and expansion plan in preparation for adult-use legalization on Oct. 17, 2018,” said Anthony Durkacz, director of FSD Pharma.
